Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesCardiologySummaCare Cardiac Event Monitor Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentSummaCarePolicy N/A

    Cardiac Event Monitors Policy

    Customize your policy alerts

    Sign up for all summacare policy alerts

    Know when summacare releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity and coverage of ambulatory external, mobile cardiac telemetry, implantable loop recorder, transtelephonic, and related electrocardiographic monitoring services for commercial and Medicare members.

    Policy Summary
    PayerSummaCare
    PolicyCardiac Event Monitors Policy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateNov 6, 2025
    Last ReviewNov 6, 2025
    Next Review DateN/A
    Key ActionDocument the symptoms, suspected arrhythmia, clinical rationale, and expected effect of monitoring on management.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    48h–30dExternal monitoring duration
    14 daysPrior monitoring for implantable recorder
    30 daysCardiac event detection package
    24 hoursMonitoring station staffing
    6Non-covered Medicare indication categories
    3Covered clinical indication categories

    Medical Necessity and Coverage Criteria

    Commercial ambulatory external cardiac monitoring

    For commercial members, ambulatory external cardiac monitoring is medically necessary when evaluating suspected cardiac arrhythmias and any one of the following criteria is met.

    Qualifying indication

    • Suspected significant arrhythmia: The patient has presyncope, syncope, or severe palpitations with clinical suspicion of a significant arrhythmia.
    • Atrial fibrillation evaluation: The monitoring evaluates atrial fibrillation for rhythm and/or rate control when results directly impact clinical decision-making and drug therapies, or evaluates suspected atrial fibrillation as the cause of cryptogenic stroke.
    • Post-ablation documentation: The monitoring documents results after an ablation procedure for arrhythmia.
    • Suspected ischemia: The monitoring documents ST-segment depression for suspected ischemia.

    Commercial mobile cardiac outpatient telemetry

    Commercial mobile cardiac outpatient telemetry is medically necessary when both the monitoring prerequisite and a qualifying indication are met.

    MCOT/MCT requirements

    • Monitoring prerequisite

      • Non-diagnostic Holter: Prior Holter monitoring was non-diagnostic.
      • Infrequent, unpredictable symptoms: Symptoms occur so infrequently and unpredictably that the planned monitoring period would likely be inadequate to capture a diagnostic ECG rhythm disorder.
    • Qualifying indication

      • Suspected significant arrhythmia: The patient has presyncope, syncope, or severe palpitations with clinical suspicion of a significant arrhythmia.

    Commercial ambulatory implantable cardiac event monitoring

    A commercial implantable loop recorder is medically necessary when both a qualifying clinical context and a qualifying monitoring criterion are present.

    Implantable loop recorder requirements

    • Qualifying clinical context

      • Unexplained syncope: The patient has an unexplained syncopal episode.
      • Relevant cardiac disease or stroke history: Cardiac arrhythmia is suspected in a patient with heart failure, prior myocardial infarction, and/or cryptogenic stroke.
    • Monitoring criterion

      • Failed external monitoring: FDA-approved ambulatory external cardiac monitoring failed to establish a definitive diagnosis, was completed in the past 2 years, and the monitor remained in place continuously for at least 14 days.

    Medicare nationally covered indications

    Medicare nationally covers the following EKG and ambulatory monitoring services when the applicable clinical, technical, documentation, and attended-monitoring requirements are met.

    Nationally covered Medicare service or indication

    • Computer EKG analysis: Computer analysis of an EKG is furnished in a setting and under circumstances that meet coverage requirements for other EKG services, including documented signs, symptoms, or another clinical indication rather than screening or routine examination.
    • IDTF EKG service: The EKG is rendered by an independent diagnostic testing facility and includes physician review and interpretation. Separate physician services are covered only when rendered by the patient's attending or consulting physician.
    • Emergency EKG: A qualifying emergency EKG is performed as a laboratory or diagnostic service by a portable x-ray supplier when a physician attends at the time of service or immediately thereafter.

    Medicare nationally non-covered indications

    The following Medicare indications are nationally non-covered unless otherwise specified.

    Nationally non-covered indication: Any of the following nationally non-covered circumstances applies: time-sampling ambulatory EKG cardiac event monitoring or recording; separate physician services other than qualifying IDTF services or services rendered by the patient's attending or consulting physician; home EKG without documented medical necessity; emergency EKG by a portable x-ray supplier without physician attendance at the time of service or immediately thereafter; 24-hour attended post-hospital myocardial infarction monitoring without the required attended-monitoring arrangement; or a marketed FDA-approved ambulatory cardiac monitoring device or service that cannot be categorized within the applicable monitoring framework.

    Covered indications and device requirements

    Coverage is available when the device and service meet the monitoring framework requirements and at least one covered clinical indication is present.

    Covered cardiac event detection framework

    • Device and service requirements: The service uses a non-insertable, patient- or event-activated device that intermittently records cardiac arrhythmic events, provides presymptom memory-loop or post-symptom recording, and transmits recordings to a monitoring station attended 24 hours a day for receipt, assessment, and appropriate management action.24-hour attended station; continuous 30-day service package
    • Covered clinical indication

      • Symptomatic transient arrhythmia: Detection, characterization, and documentation of symptomatic transient arrhythmias when symptoms are infrequent and a 24-hour ambulatory EKG is unlikely to capture and document the arrhythmia.

    Monitoring duration

    The cardiac event detection service may be discontinued before 30 days when the clinical objective has been met.

    Permitted early discontinuation: The event recorder may be discontinued once the symptom-producing arrhythmia has been documented and diagnosed, or after multiple transmissions during symptoms show no arrhythmia.30-day service package

    The service remains defined as a 30-day service even when discontinued early; the anticipated average monitoring duration is 10–14 days or more.

    For Medicare, the time-sampling mode of ambulatory EKG cardiac event monitoring or recording is nationally non-covered.

    Home EKG services are nationally non-covered for Medicare when documentation does not establish medical necessity.

    Emergency EKG services furnished by a portable x-ray supplier are nationally non-covered when a physician is not in attendance at the time of service or immediately thereafter.

    An FDA-approved ambulatory cardiac monitoring device or service is nationally non-covered when it cannot be categorized within the applicable monitoring framework.

    Cardiac event detection is not covered for patients in hospitals, emergency rooms, skilled nursing facilities, or other specialized facilities. It is also not covered for outpatient or facility-based cardiac monitoring.

    Event recorders are not covered for outpatient monitoring of recently discharged post-infarct patients; such services are considered not medically necessary.

    Ambulatory external cardiac monitoring, outpatient cardiac telemetry, and ambulatory implantable cardiac event monitoring are considered experimental and investigational for indications other than those listed in the policy because effectiveness for those indications has not been established.

    Cardiac event detection is not medically necessary when it is unlikely to provide new clinical data beyond prior testing or when another test is better suited to the patient's condition. The service should be coordinated with standard EKG, Holter monitor, and stress-test results; it is not appropriate when only a standard EKG or rhythm strip is needed, for routine daily transmission without identified symptoms, or when significant recurrent arrhythmias requiring treatment are not anticipated.

    Testing for more than 30 consecutive days is only rarely medically necessary and requires treating-physician justification. Failure to document an arrhythmia during a 30-day test does not by itself justify a subsequent test, and repeat testing within one year is generally not medically necessary without new or recurrent undiagnosed symptoms.

    Patient-activated event recording is not medically necessary when the patient is unresponsive, comatose, severely confused, unable to recognize symptoms, unable to activate the recorder, or unable to participate in device use.

    Each patient must have exclusive use of a recorder throughout the monitoring period. Recorders may not be shared among patients, and claims are denied when exclusive use is not maintained for the entire 30-day service period.

    Coding and Service Parameters

    Cardiac event monitor codesCPT
    93228External electrocardiographic recording, up to 30 days; physician review and interpretation, with report
    93229External electrocardiographic recording, up to 30 days; recording, scanning analysis with report, review and interpretation
    Ambulatory External Cardiac Monitoring (ZIO Patch)CPTCovered
    93241External electrocardiographic recording, greater than 48 hours up to 7 days; recording, analysis with report
    93242External electrocardiographic recording, greater than 48 hours up to 7 days; hookup and connection
    93243External electrocardiographic recording, greater than 48 hours up to 7 days; scanning analysis with report
    93244External electrocardiographic recording, greater than 48 hours up to 7 days; physician review and interpretation
    93245External electrocardiographic recording, greater than 7 days up to 15 days; recording, analysis with report
    93246External electrocardiographic recording, greater than 7 days up to 15 days; hookup and connection
    93247External electrocardiographic recording, greater than 7 days up to 15 days; scanning analysis with report
    93248External electrocardiographic recording, greater than 7 days up to 15 days; physician review and interpretation
    93268External patient-activated electrocardiographic rhythm-derived event recording, up to 30 days; recording, analysis with report
    93270External patient-activated electrocardiographic rhythm-derived event recording, up to 30 days; hookup and connection
    1–10 of 14
    1/2
    Ambulatory Implantable Cardiac Event MonitoringmixedCovered
    33285Insertion of subcutaneous cardiac rhythm monitor, including programming
    C1764Monitor, cardiac, implantable
    E0616Automatic external defibrillator, with integrated electrocardiogram analysis, garment type
    Ambulatory external monitoring duration
    Monitoring typeAmbulatory external cardiac monitoring
    Coverage duration48 hours up to 30 days
    Covered useEvaluation of suspected arrhythmia, atrial fibrillation, post-ablation results, or suspected ischemia
    Prior external monitoring duration for implantable recorder
    Prior monitoring typeFDA-approved ambulatory external cardiac monitoring
    Required durationContinuous monitoring for 14 days or more

    Authorization, Documentation, and Denial Risks

    Prior Authorization

    Authorization for Cardiac Event Monitoring

    For commercial members, cardiac event monitoring requires authorization when used to evaluate a suspected cardiac arrhythmia. Submit the applicable clinical indication and supporting documentation with the request.

    • Applicable commercial monitoring includes ambulatory external monitoring, MCOT/MCT, and implantable loop recorder services.
    Documentation Required

    Clinical Indication and Monitoring History

    Document the symptoms or clinical circumstance prompting monitoring, the suspected arrhythmia, the rationale for the selected modality and duration, and how results will affect management. Include relevant monitoring history, including prior Holter or ambulatory monitoring and its diagnostic outcome.

    • Document presyncope, syncope, severe palpitations, suspected or known atrial fibrillation, cryptogenic stroke evaluation, post-ablation assessment, suspected ischemia, or other applicable indication.

    Clinical Background

    Cardiac event monitors are portable EKG devices worn during normal activity, generally for up to 30 days, to capture intermittent arrhythmias that may not appear on a routine EKG or 24-hour Holter monitor. Devices may be patient-activated, automatically triggered, or capable of continuous mobile telemetry with remote transmission and clinical review.

    Definitions and Service Terms

    Cardiac event monitor
    DeviceSmall, portable EKG recording device
    Use periodWorn during normal activity for up to 30 days
    Recording functionStores several minutes of cardiac activity and allows the patient to initiate recording during symptomatic arrhythmia
    Mobile cardiac telemetry (MCT)
    Device typeNon-invasive ambulatory cardiac event monitor
    MeasurementContinuously measures heart rate and rhythm over several days
    Transmission
    Policy Summary
    PayerSummaCare
    PolicyCardiac Event Monitors Policy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateNov 6, 2025
    Last ReviewNov 6, 2025
    Next Review DateN/A
    Key ActionDocument the symptoms, suspected arrhythmia, clinical rationale, and expected effect of monitoring on management.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaCoding and Service ParametersAuthorization, Documentation, and Denial RisksClinical BackgroundDefinitions and Service Terms
  1. Atrial fibrillation evaluation: The monitoring evaluates atrial fibrillation for rhythm and/or rate control when results directly impact clinical decision-making.
  2. Completed in the past 2 years; continuous 14 days or more
  3. External monitoring unlikely to be diagnostic: External monitoring is not expected to be diagnostic because symptoms occur so infrequently and unpredictably that the monitoring period would likely be inadequate to capture a diagnostic ECG rhythm disorder.
  4. Home EKG: The home EKG service has documented medical necessity.
  5. Transtelephonic EKG transmission

    • Technical requirements: The transmitting device can transmit EKG lead I, II, or III, and the tracing is sufficiently comparable to a conventional EKG.
    • Applicable transtelephonic indication

      • Transient arrhythmia: Detection, characterization, and documentation of symptomatic transient arrhythmias.
      • Antiarrhythmic therapy: Initiation, revision, or discontinuation of arrhythmic drug therapy.
      • Early post-MI monitoring

        • Attended monitoring arrangement: An EKG technician or other non-physician at a monitoring site or central data center receives calls and/or EKG data, has immediate 24-hour access to a physician for review and clinical decisions, and is instructed when and how to contact available facilities in an emergency.24-hour attended coverage
  6. Antiarrhythmic medication management:
    Regulation of antiarrhythmic drug dosage when monitoring is needed to assess treatment efficacy.
  7. Post-procedure monitoring: Monitoring a patient who has undergone a surgical or ablative procedure for arrhythmia.
  8. Completion windowCompleted within the past 2 years
  9. Explain the expected impact on rhythm or rate control, antiarrhythmic therapy, or diagnostic decision-making.
  10. For implantable monitoring, document the qualifying heart-failure, prior-myocardial-infarction, cryptogenic-stroke, or unexplained-syncope context and prior monitoring history.
  11. Documentation Required

    Medical Necessity Documentation

    Medicare EKG and ambulatory EKG services require documented signs, symptoms, or other clinical indications. The record should support diagnostic use or evaluation of response to initiation, revision, or discontinuation of arrhythmic drug therapy; screening and routine examination uses are not covered except for the specified Welcome to Medicare examination.

    • Document symptoms such as syncope, dizziness, chest pain, palpitations, or shortness of breath, or another specific clinical indication.
    • Document physician review and interpretation when required.
    Documentation Required

    Technical and Attended-Monitoring Documentation

    Before submitting a transtelephonic or attended-monitoring claim, verify that the device and tracing meet Medicare technical requirements. The transmitted tracing must be sufficiently comparable to a conventional EKG.

    • The transmitting device must be capable of transmitting EKG leads I, II, or III.
    • Do not use time-sampling technology for covered ambulatory event monitoring.
    Documentation Required

    Order and Supporting Diagnostic Evaluation

    The test must be ordered by the treating physician or qualified nonphysician practitioner. The order and record should identify the indication, relevant diagnostic results, and coordination with prior standard EKG, Holter, and stress-test findings.

    • Retain the ordering practitioner's order and supporting clinical documentation.
    • Coordinate the event-detection service with available prior diagnostic results.
    Documentation Required

    Symptoms, Findings, and Duration Rationale

    Support the requested monitoring period with the frequency and unpredictability of symptoms and the likelihood of capturing a diagnostic rhythm. Document transmissions, findings, and the suspected paroxysmal or transient arrhythmia; monitoring may stop once the symptom-producing arrhythmia is documented or after multiple symptomatic transmissions without arrhythmia.

    • Explain why a 24-hour ambulatory EKG is unlikely to capture the event when symptoms are limited or intermittent.
    • For a 30-day service, document the pre-test symptom incidence and the rationale for the expected duration; the anticipated average duration is approximately 10–14 days or more, though the service is packaged for 30 days.
    Documentation Required

    Operational Monitoring Requirements

    Use a monitoring station with continuous qualified EKG-reading coverage and emergency-management capability. An answering service, answering machine, or relay-only computer system does not satisfy the attended-monitoring requirement.

    • Provide 24-hour staffing by personnel trained to read EKGs, such as critical-care nurses or paramedics.
    • Personnel must be able to direct emergency management and have immediate 24-hour access to a physician when required.
    Denial Risk

    External Monitoring Without a Qualifying Indication

    Ambulatory external monitoring is at risk for denial when the patient lacks a qualifying clinical indication. Presyncope, syncope, or severe palpitations must be accompanied by clinical suspicion of a significant arrhythmia when those indications are used.

    • Do not request external monitoring solely for screening, routine monitoring, or nonspecific symptoms without a documented qualifying indication.
    Denial Risk

    MCOT/MCT Prerequisite Monitoring Rationale

    MCOT/MCT is medically necessary only when prior monitoring is nondiagnostic or symptoms are so infrequent and unpredictable that the prior or shorter monitoring period would likely not capture the rhythm. Document that prerequisite rationale before requesting telemetry.

    • Document a nondiagnostic Holter result, or explain why symptom frequency and unpredictability make the monitoring period inadequate.
    • Also document presyncope, syncope, or severe palpitations with suspected significant arrhythmia, or atrial-fibrillation evaluation affecting clinical decision-making.
    Denial Risk

    Implantable Recorder Without Qualifying Criteria

    An implantable loop recorder requires a qualifying clinical context and monitoring rationale. Without unexplained syncope or suspected arrhythmia in the specified heart-failure, prior-myocardial-infarction, or cryptogenic-stroke context, the service is at risk for denial.

    • Document FDA-approved external monitoring completed within the past 2 years that failed to establish a definitive diagnosis and remained in place continuously for at least 14 days; or document why symptoms are too infrequent and unpredictable for external monitoring to be diagnostic.
    Denial Risk

    Non-Covered Monitoring Configuration or Service

    Certain monitoring configurations and services are nationally non-covered. Do not bill unsupported time-sampling monitoring, home EKG without medical-necessity documentation, or emergency EKG by a portable x-ray supplier without physician attendance.

    • Time-sampling operation of ambulatory EKG event monitoring is non-covered.
    • Separate physician services outside an IDTF are non-covered unless provided by the patient's attending or consulting physician.
    • A marketed FDA-approved device or service that cannot be categorized within the covered framework is non-covered.
    Denial Risk

    No Additional Clinical Value

    Cardiac event detection is medically unnecessary when it offers little or no potential for new clinical data beyond a prior test or when another test is better suited to the patient's condition.

    • Review and coordinate prior standard EKG, Holter-monitor, and stress-test results before ordering another event-detection service.
    • Do not repeat testing when existing results already establish the diagnosis or another test would obtain the relevant information more appropriately.
    Denial Risk

    Inadequate Monitoring-Station Staffing

    The receiving station must maintain continuous 24-hour staffing by personnel trained to read EKGs and direct management of emergencies. A system without this staffing model does not meet the operational requirement.

    • An answering service or answering machine does not qualify.
    • Computer relay systems that only dial a physician's office are not covered because they lack 24-hour personnel attendance.
    Denial Risk

    No Qualifying Practitioner Order

    A cardiac event-detection test not ordered by the treating physician or qualified nonphysician practitioner will be denied as not medically necessary.

    • Ensure the order comes from a practitioner treating the beneficiary and is supported by the documented indication.
    Denial Risk

    Routine or Non-Diagnostic Monitoring

    Cardiac event detection is intended for long-term diagnostic monitoring of suspected or paroxysmal dysrhythmia, or for evaluating a patient actively managed with arrhythmic medication. It is not covered when only a standard EKG or rhythm strip is needed or for routine daily transmissions without identified symptoms.

    • Do not use a CED service merely to transmit a standard EKG or rhythm strip.
    • Routine daily transmission or monitoring without a diagnostic purpose is non-covered.
    Denial Risk

    Insufficient Recurrent Arrhythmia Symptoms

    The requested service must be supported by a reasonable expectation of significant recurrent arrhythmias that require treatment. Monitoring is not medically necessary when treatable recurrent arrhythmias are not anticipated.

    • Document the pre-test symptom frequency, suspected arrhythmia, and anticipated treatment or management consequence.
    Denial Risk

    Excluded Care Settings

    Cardiac event detection is not covered for patients in hospitals, emergency rooms, skilled nursing facilities, or other specialized facilities. It is also not covered for outpatient or facility-based cardiac monitoring as described in the limitations.

    • Confirm that the requested service is provided in an eligible setting and is not duplicative facility-based monitoring.
    Denial Risk

    Non-Diagnostic or Non-Treatment Use

    Event recorders are covered only as diagnostic tests or to evaluate a patient who is actively being managed with antiarrhythmic medication. Routine, screening, or non-treatment use is not covered.

    • Document the diagnostic question or active antiarrhythmic-management decision the test will address.
    Denial Risk

    Unsupported Extended or Repeat Testing

    Testing beyond 30 consecutive days is rarely medically necessary and requires treating-physician justification. An unrevealing 30-day test alone does not justify a second or subsequent test, and repeat testing within one year is unlikely to be necessary without new or recurrent undiagnosed symptoms.

    • Document the specific reason continued testing is required beyond 30 days.
    • Do not repeat within a year absent new or recurrent undiagnosed symptoms and supporting medical necessity.
    Denial Risk

    Patient Unable to Operate Device

    Patient-activated event recording is not medically necessary when the patient cannot recognize symptoms, activate the recorder, or participate in use of the device.

    • Assess and document the patient's responsiveness, cognition, and ability to use the recorder throughout the monitoring period.
    Denial Risk

    Recently Discharged Post-Infarct Monitoring

    Event recorders are not covered for outpatient monitoring of recently discharged post-infarct patients and will be denied as not medically necessary.

    • Do not submit outpatient event-recorder monitoring for a recently discharged post-infarct patient under this indication.
    Denial Risk

    Shared Recorder

    Each patient must have a recorder for exclusive use throughout the entire monitoring period. Shared equipment does not meet the coverage requirement, regardless of the environment or service site.

    • Maintain exclusive recorder assignment for the full 30-day service period.
    • Claims may be denied when a recorder is shared by two or more patients.
    Billing Rule

    Improper Repeat Billing Within 30 Days

    Cardiac event detection is a packaged 30-day service. Tests may not be billed within 30 days of one another, even when the first test ended after an arrhythmia was documented and the patient is reconnected for follow-up therapy or intervention.

    • Apply the 30-day packaged-service billing rule to repeat or follow-up connections.
    • Do not separately bill another test within 30 days of the earlier test.
    Transmits results to a remote monitoring center
    Implantable or insertable loop recorder
    PlacementImplanted subcutaneously in the upper left chest
    DurationMay remain implanted for many months
    Use caseUsed when suspected cardiac syncope is too infrequent to be detected by a Holter monitor or traditional pre-symptom memory-loop recorder
    Ambulatory electrocardiography (AECG)
    ServiceAmbulatory EKG performed over a specified outpatient period
    Patient activityPerformed while the patient engages in daily activities, including sleep
    Clinical purposeDocuments intermittent arrhythmias or myocardial ischemia and evaluates response to antiarrhythmic drug therapy
    Cardiac event detection (CED)
    Monitoring serviceLong-term monitoring for a suspected or paroxysmal dysrhythmia
    Recording methodA patient or event activates an intermittently recording, non-insertable device
    Data handlingRecorded data are transmitted to a qualified, continuously staffed station for EKG assessment and management action
    30-day packaged service
    Service periodOne continuous 30-day period
    Included recordingsAll recordings made during the service period
    Included servicesAll transmissions and interpretations during the service period
    Patient/event-activated recording
    Presymptom methodRecords before symptoms through presymptom memory-loop technology
    Post-symptom methodRecords after the patient activates the monitor at symptom onset
    ActivationRecording may be initiated by the patient or by an event detected by the device